參考文獻(xiàn)/References:
[1] ZHENG C J,CHEN J.Disc degeneration implies low back pain[J].Theor Biol Med Model, 2015,12:24.
[2] KENNETH C,JARO K,HO D,et al.Prevalence and pattern of lumber magnetic resonance imaging changes in a population study of one thousand forty-three individuals[J]. Spin(Phila Pa 1976), 2009, 34(9): 934-940.
[3] PENNICOOKE B,MORIGUCHI Y,HUSSAIN I,et al.Biological treatment approaches for degenerative disc disease:a review of clinical trials and future directions[J].Cureus,2016,8(11): e892.
[4] LEE K I,MOON S H,KIM H,et al.Tissue engineering of the intervertebral disc with cultured nucleus pulposus cells using atelocollagen scaffold and growth factors[J]. Spine, 2012, 37(6): 452-458.
[5] SUN Z Y,YIN Z M,LIU C,et al.IL-1β promotes ADAMTS enzyme-mediated aggrecan degradation through NF-κB in human intervertebral disc [J].J Orthop Surg Res,2015,10:159.
[6] 劉汝銀,彭曉艷,岳宗進(jìn),等.四環(huán)素聯(lián)合桂枝加葛根湯對(duì)髓核細(xì)胞增殖和相關(guān)因子表達(dá)的影響[J].中國(guó)脊柱脊髓雜志,2018,28(5):463-469.
[7] 徐無(wú)忌,楊康,劉思華.六味地黃丸對(duì)椎間盤(pán)體外退變模型椎間盤(pán)細(xì)胞外基質(zhì)組分的影響[J].中國(guó)組織工程研究,2017,21(16):2495-2501.
[8] 鄭先波,徐無(wú)忌.六味地黃丸對(duì)兔椎間盤(pán)退變模型髓核細(xì)胞p38MAPK信號(hào)級(jí)聯(lián)JNK通路的影響[J].中醫(yī)藥導(dǎo)報(bào),2017,23(2):11-16.
[9] 王樂(lè).六味地黃丸對(duì)兔椎間盤(pán)退變模型椎間盤(pán)細(xì)胞外基質(zhì)組分的影響[D].長(zhǎng)沙:湖南中醫(yī)藥大學(xué),2015.
[10] 周紅海,姜宏,俞振翰.益氣活血方對(duì)非破裂型腰椎間盤(pán)突出退變髓核細(xì)胞ColⅡ、Aggrecan及TIMP-1 mRNA的影響[J].南京中醫(yī)藥大學(xué)學(xué)報(bào),2015,31(4):368-371.
[11] 謝林,施杞,沈培芝,等.芪麝頸康丸對(duì)頸椎間盤(pán)髓核細(xì)胞超微結(jié)構(gòu)的影響[J].中國(guó)中醫(yī)骨傷科雜志,2003,11(2):12-15.
[12] 勞楊駿,王繼濤,徐濤濤,等.椎間盤(pán)退變前驅(qū)因素終板退變研究現(xiàn)狀[J].中華中醫(yī)藥雜志,2017,32(9):4098-4101.
[13] JIA H,MA J,LV J,et al.Oestrogen and parathyroid hormone alleviate lumbar intervertebral disc degeneration in ovariectomized rats and enhance Wnt/β-catenin pathway activity[J].Sci Rep,2016,6:27521.
[14] PENG B,HOU S,SHI Q,et al.The relationship between cartilage end-plate calcification and disc degeneration:an experimental study[J].Chinese Medical Journal,2001,114(3):308-312.
[15] LOTZ J C,FIELDS A J,LIEBENBERG E C.The role of the vertebral end plate in low back pain[J].Global Spine J,2013,3(3):153-164.
[16] 朱立國(guó),張平,宋慶慧,等.補(bǔ)腎活血方對(duì)沙鼠增齡過(guò)程中腰椎軟骨終板鈣化干預(yù)作用的初步研究[J].中國(guó)骨傷,2017,30(10):926-932.
[17] 呂存賢,吳永琴.補(bǔ)陽(yáng)還五湯對(duì)兔腰椎間盤(pán)退變模型中軟骨終板的影響[J].海峽藥學(xué),2011,23(3):39-41.
[18] 呂存賢,吳永琴.補(bǔ)陽(yáng)還五湯對(duì)兔退變椎間盤(pán)中軟骨終板血管芽的影響及意義[J].海峽藥學(xué),2012,24(2):33-34.
[19] 呂存賢,吳永琴.補(bǔ)陽(yáng)還五湯對(duì)兔退變椎間盤(pán)軟骨終板Fas/FasL表達(dá)的影響[J].中國(guó)中醫(yī)藥科技,2012,19(3):214-215.
[20] 劉汝專(zhuān),劉金浪,郭艷軍,等.溶髓方對(duì)大鼠椎間盤(pán)退變中軟骨終板IL-1β的影響[J].遼寧中醫(yī)雜志,2014,41(6):1284-1287.
[21] 劉汝專(zhuān),潘漢升,唐曉菊,等.溶髓方對(duì)頸椎間盤(pán)退變大鼠軟骨終板細(xì)胞凋亡的影響[J].廣西中醫(yī)藥大學(xué)學(xué)報(bào),2014,17(2):7-10.
中醫(yī)正骨2019年4月第31卷第4期 J Trad Chin Orthop Trauma,2019,Vol.31,No.4(總279)
(總280)中醫(yī)正骨2019年4月第31卷第4期 J Trad Chin Orthop Trauma,2019,Vol.31,No.4
[22] 王擁軍,施杞,周重建,等.益氣化瘀方對(duì)大鼠頸椎間盤(pán)軟骨終板內(nèi)血管的影響[J].中國(guó)中醫(yī)骨傷科雜志,2002,10(4):3-6.
[23] 王藝儒,梁倩倩,唐德志,等.桃仁-紅花藥對(duì)對(duì)動(dòng)靜力失衡性大鼠椎間盤(pán)軟骨終板細(xì)胞老化及凋亡的影響[J].環(huán)球中醫(yī)藥,2018,11(4):497-501.
[24] 牛凱,李晨光,袁松,等.桃仁-紅花藥對(duì)抑制IL-1β誘導(dǎo)椎間盤(pán)軟骨終板細(xì)胞發(fā)生退變的體外實(shí)驗(yàn)研究[J].中國(guó)藥學(xué),2016,25(8):590-597.
[25] 肖志鋒,林定坤,蘇國(guó)義,等.阿倫磷酸鈉聯(lián)合腎骨安對(duì)去勢(shì)小鼠終板結(jié)構(gòu)和椎間盤(pán)退變的影響[J].中國(guó)脊柱脊髓雜志,2017,18(12):1128-1134.
[26] 張瀟瀟,姜宏,張志剛,等.腫瘤壞死因子與腰椎間盤(pán)退變的相關(guān)性研究進(jìn)展[J].中國(guó)中醫(yī)骨傷科雜志,2017,25(12):79-82.
[27] WANG C,YU X H,YAN Y G,et al.Tumor necrosis factor-alpha:a key contributor to intervertebral disc degeneration[J].Acta Biochimica et Biophysica Sinica,2017,49(1): 1-13.
[28] 劉仁,吳官保,馮帥華,等.補(bǔ)腎活血湯對(duì)腰椎間盤(pán)退變大鼠TNF-α表達(dá)的影響[J].湖南中醫(yī)雜志,2017,33(3):144-145.
[29] 仇湘中,蔣盛昶,張信成,等.補(bǔ)肝健腰方對(duì)腰椎間盤(pán)退變大鼠髓核組織TNF-α、IL-1β干預(yù)作用的研究[J].湖南中醫(yī)藥大學(xué)學(xué)報(bào),2015,35(4):17-19.
[30] 孫江濤,李宇衛(wèi),沈曉峰,等.枳殼甘草湯對(duì)腰椎間盤(pán)突出模型大鼠炎癥及退變的影響[J].中國(guó)中醫(yī)急癥,2016,25(8):1488-1492.
[31] 黃曉濤,馬鎮(zhèn)川,呂存賢,等.血府逐瘀湯對(duì)兔椎間盤(pán)退變模型軟骨組織中TNF-α的影響[J].浙江中西醫(yī)結(jié)合雜志,2010,20(8):468-469.
[32] 林向全,鄭忠,李超雄,等.細(xì)胞因子在椎間盤(pán)退變中的研究進(jìn)展[J].湖南中醫(yī)雜志,2016,32(12):185-188.
[33] DINARELLO C A.Immunological and inflammatory functions of the interleukin-1 family[J].Annual Review of Immunology,2009,27:519-550.
[34] PALOMO J,DIETRICH D,MARTIN P,et al.The interleukin(IL)-1 cytokine family - Balance between agonists and antagonists in inflammatory diseases[J].Cytokine,2015,76(1):25-37.
[35] GENEVAY S,FINCKH A,MEZIN F,et al.Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation[J].Arthritis Res Ther,2009,11(6):R169.
[36] 馮帥華,劉仁,吳官保,等.補(bǔ)腎活血湯對(duì)D-半乳糖致腰椎間盤(pán)退變大鼠模型IL-1β,TGF-β1表達(dá)的影響[J].中醫(yī)藥導(dǎo)報(bào),2018,24(4):11-13.
[37] 陳榮國(guó),孫強(qiáng),曾懌,等.雷公藤紅素對(duì)IL-1β致軟骨終板退變的影響[J].中國(guó)骨質(zhì)疏松雜志,2017,23(12):1629-1632.
[38] 譚務(wù)華,熊惠秀,謝志明,等.痰濕方對(duì)慢性咽炎及痰濕阻絡(luò)型頸椎病模型兔炎性因子及椎間盤(pán)退變的影響[J].中醫(yī)學(xué)報(bào),2018,33(8):1467-1471.
[39] 周樺,盧建華.獨(dú)活寄生湯對(duì)椎間盤(pán)內(nèi)紊亂兔模型髓核組織中IL-1β及PGE_2的影響[J].中華中醫(yī)藥雜志,2016,31(2):665-667.
相似文獻(xiàn)/References:
[1]張莉,秦丹霞,張細(xì)姣.腹針治療椎間盤(pán)源性腰痛[J].中醫(yī)正骨,2015,27(10):38.
[2]吳青坡,孫國(guó)紹,王林杰.后路椎管減壓聯(lián)合腰椎椎弓根釘動(dòng)態(tài)穩(wěn)定裝置內(nèi)固定
治療單節(jié)段腰椎退行性疾病[J].中醫(yī)正骨,2015,27(10):42.
[3]李文雄,張晶宇,楊鋒.中藥調(diào)控骨髓間充質(zhì)干細(xì)胞成骨分化的研究進(jìn)展[J].中醫(yī)正骨,2016,28(07):68.
[4]王樂(lè),徐無(wú)忌.六味地黃丸對(duì)兔椎間盤(pán)退變模型椎間盤(pán)組織中Ⅰ、Ⅱ型膠原表達(dá)的影響[J].中醫(yī)正骨,2016,28(08):1.
WANG Le,XU Wuji.Effect of Liuwei Dihuang Wan(六味地黃丸)on typeⅠandⅡcollagen expression in intervertebral disc of rabbit model of intervertebral disc degeneration[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(04):1.
[5]張澤宇,舒永輝,朱權(quán),等.中藥內(nèi)服和薰洗在脛骨平臺(tái)骨折術(shù)后治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(11):17.
ZHANG Zeyu,SHU Yonghui,ZHU Quan,et al.Oral application of traditional Chinese medicine and Chinese herbal steaming washing therapy for postoperative treatment of tibial plateau fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(04):17.
[6]夏炳江,童培建.適宜中醫(yī)藥研究的椎間盤(pán)退變動(dòng)物模型的構(gòu)建[J].中醫(yī)正骨,2016,28(11):71.
[7]程濤,黃家駿.中藥內(nèi)服治療急性軟組織損傷的研究進(jìn)展[J].中醫(yī)正骨,2017,29(01):39.
[8]郝勝坤,紀(jì)斌,石繼祥,等.補(bǔ)腎活血中藥治療膝骨關(guān)節(jié)炎的作用機(jī)制[J].中醫(yī)正骨,2017,29(04):31.
[9]陳羅西,劉波,張曉芳,等.傳統(tǒng)關(guān)節(jié)黏連松解術(shù)聯(lián)合中藥內(nèi)服外敷治療骨化性肌炎并發(fā)關(guān)節(jié)僵硬[J].中醫(yī)正骨,2017,29(04):76.
[10]劉啟明,羅統(tǒng)富,董黎強(qiáng),等.植物雌激素類(lèi)中藥延緩關(guān)節(jié)軟骨細(xì)胞退變的研究進(jìn)展[J].中醫(yī)正骨,2017,29(05):27.